Objective To investigate the risk factors for kidney injury during anti-retroviral therapy (ART) with zidovudine(AZT) or tenofovir disoproxil fumarate(TDF) in human immunodeficiency virus/acquired immunodeficiency syn...Objective To investigate the risk factors for kidney injury during anti-retroviral therapy (ART) with zidovudine(AZT) or tenofovir disoproxil fumarate(TDF) in human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS) patients,and to construct and validate a prediction model for the risk of kidney injury in HIV/AIDS patients based on a nomogram.展开更多
To the Editor:We read with great interest the recent article by Shi et al.pub-lished in Hepatobiliary Pancreatic Diseases International[1].Shi’s study was based on radiological features and clinical factors to constr...To the Editor:We read with great interest the recent article by Shi et al.pub-lished in Hepatobiliary Pancreatic Diseases International[1].Shi’s study was based on radiological features and clinical factors to construct a model to predict the effectiveness of first transarterial chemoembolization(TACE)treatment for hepatocellular carcinoma(HCC)in prolonging patient survival.The results showed that area under the receiver operating characteristic curve was 0.964 for the training cohort and 0.949 for the validation cohort.展开更多
文摘Objective To investigate the risk factors for kidney injury during anti-retroviral therapy (ART) with zidovudine(AZT) or tenofovir disoproxil fumarate(TDF) in human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS) patients,and to construct and validate a prediction model for the risk of kidney injury in HIV/AIDS patients based on a nomogram.
基金supported by a grant from the Nursing Re-search Program of the First Affiliated Hospital of Zhejiang Univer-sity School of Medicine(No.2022ZYHL045).
文摘To the Editor:We read with great interest the recent article by Shi et al.pub-lished in Hepatobiliary Pancreatic Diseases International[1].Shi’s study was based on radiological features and clinical factors to construct a model to predict the effectiveness of first transarterial chemoembolization(TACE)treatment for hepatocellular carcinoma(HCC)in prolonging patient survival.The results showed that area under the receiver operating characteristic curve was 0.964 for the training cohort and 0.949 for the validation cohort.
